Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Single-dose SEP-380135 Study in Healthy Japanese Male Volunteers
jRCT2071250041Phase 1Active, not recruiting
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing SEP-380135 with Placebo (2 arms). Primary endpoints: Safety endpoints and Pharmacokinetic endpoints. Started Aug 2025; status: active, not recruiting.
02
Drugs
SEP-380135
Beyond the preview
Go deeper on jRCT2071250041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250041.